| 2021-12-13 | +101.6% | M&A | SEC EDGAR | RNVA 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2021-12-03 | +99.7% | news | Seeking Alpha | Rennova Health owned hospital receives critical access hospital certification |
| 2022-03-16 | -94.4% | news | Seeking Alpha | Rennova Health completes reverse stock split, trading starts today |
| 2022-03-16 | -94.4% | M&A | SEC EDGAR | RNVA 8-K: 1.01, 3.02, 5.03 (SEC Filing) |
| 2021-07-16 | -59.4% | M&A | SEC EDGAR | RNVA 8-K: 1.01 and 3.02 (SEC Filing) |
| 2021-07-09 | -51.4% | news | Seeking Alpha | Rennova Health to enter 1 for 1,000 reverse stock split |
| 2021-12-17 | -47.5% | news | SEC EDGAR | RNVA 8-K: 5.07 and 8.01 (SEC Filing) |
| 2021-08-16 | -42.9% | M&A | SEC EDGAR | RNVA 8-K: 2.01 and (SEC Filing) |
| 2021-10-04 | +40.3% | M&A | SEC EDGAR | RNVA 8-K: 1.01, 3.02and8.01 (SEC Filing) |
| 2021-09-08 | -35.6% | M&A | SEC EDGAR | RNVA 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2021-07-12 | -33.3% | news | SEC EDGAR | RNVA 8-K: 8.01 and (SEC Filing) |
| 2021-11-08 | -33.1% | M&A | SEC EDGAR | RNVA 8-K: 1.01, 3.02, 3.03, 5.03 (SEC Filing) |
| 2021-09-02 | -31.9% | M&A | SEC EDGAR | RNVA 8-K: 1.01, 3.02, 5.07 (SEC Filing) |
| 2022-04-07 | -25.9% | M&A | SEC EDGAR | RNVA 8-K: 1.01, 3.02 (SEC Filing) |
| 2021-07-01 | -15.6% | M&A | SEC EDGAR | RNVA 8-K: 2.01 (SEC Filing) |
| 2021-05-11 | -15.2% | M&A | SEC EDGAR | RNVA 8-K: 1.01, 3.02, 5.03, 8.01 (SEC Filing) |
| 2021-05-24 | -11.9% | M&A | SEC EDGAR | RNVA 8-K: 1.01 and 3.02 (SEC Filing) |
| 2021-08-13 | +4.8% | M&A | SEC EDGAR | RNVA 8-K: 1.01 and 3.02 (SEC Filing) |
| 2022-09-23 | +2.6% | news | SEC EDGAR | RNVA 8-K: 8.01 and (SEC Filing) |
| 2022-03-10 | +1.7% | news | SEC EDGAR | RNVA 8-K: 8.01 and (SEC Filing) |
| 2022-09-27 | -1.7% | news | GuruFocus | Jason Adams Net Worth (2026) - GuruFocus |
| 2023-10-31 | -1.7% | M&A | SEC EDGAR | RNVA 8-K: 1.01 and (SEC Filing) |
| 2022-02-01 | -1.7% | M&A | SEC EDGAR | RNVA 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2022-11-08 | +1.5% | news | GuruFocus | Seamus Lagan Net Worth (2026) - GuruFocus |
| 2021-10-28 | -1.2% | M&A | SEC EDGAR | RNVA 8-K: 1.01, 3.02, 8.01 (SEC Filing) |
| 2024-06-17 | -1.1% | M&A | SEC EDGAR | RNVA 8-K: 1.01, 7.01, 8.01 (SEC Filing) |
| 2024-06-14 | -0.9% | M&A | SEC.gov | FOXO Technologies Enters into Share Exchange Agreements to Acquire Healthcare Operations from Rennova Health, Inc. - SEC.gov |
| 2025-04-25 | -0.8% | news | Stock Titan | RNVA Stock Price, News & Analysis - Stock Titan |
| 2025-04-25 | -0.8% | news | Stock Titan | ICBU Stock Price, News & Analysis - Stock Titan |
| 2024-03-26 | -0.7% | M&A | SEC EDGAR | RNVA 8-K: 1.01 and (SEC Filing) |
| 2022-11-23 | -0.6% | news | SEC EDGAR | RNVA 8-K: 8.01 and (SEC Filing) |
| 2024-11-08 | -0.5% | news | SEC EDGAR | RNVA 8-K: 8.01 and (SEC Filing) |
| 2025-05-06 | +0.4% | news | Stock Titan | CNTGF Stock Price, News & Analysis - Stock Titan |
| 2024-09-17 | +0.3% | earnings | GlobeNewswire | Foxo Technologies, Inc., Completes the Acquisition of Revenue Generating Operations From Rennova Health, Inc. - GlobeNewswire |
| 2021-06-28 | -0.3% | news | SEC EDGAR | RNVA 8-K: 8.01 and (SEC Filing) |
| 2024-09-20 | +0.2% | M&A | SEC EDGAR | RNVA 8-K: 1.01, 2.01 (SEC Filing) |
| 2023-04-30 | +0.1% | analyst | Zacks Investment Research | What is the current Price Target and Forecast for Rennova Health (RNVA) - Zacks Investment Research |
| 2022-11-14 | +0.0% | news | GuruFocus | Nicholas Matthew Maounis Net Worth (2026) - GuruFocus |